NCT05785975

Brief Summary

In order to encourage the population at risk to participate in colorectal cancer screening, this clustered trial intends to determine the efficacy of specific messages(Nudge), single FIT testing, and the primary care physician's clinical judgment on referral to colonoscopy. It primarily seeks to provide answers to the following questions: How effective is the modified integrated CRC screening system (MICRCSS) for individuals with average colorectal cancer risk? based on the percentage of individuals who had CRC screening, registered for the follow-up, and were discovered to have precancerous CRC issues a year after the program's start, as contrasted to individuals receiving standard medical care? All public government entities in the Hail region will be contacted with invitations to participate in the study (outreach). the organization

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
2,520

participants targeted

Target at P75+ for not_applicable colorectal-cancer

Timeline
Completed

Started Jun 2023

Shorter than P25 for not_applicable colorectal-cancer

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 27, 2023

Completed
28 days until next milestone

First Posted

Study publicly available on registry

March 27, 2023

Completed
3 months until next milestone

Study Start

First participant enrolled

June 15, 2023

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 15, 2023

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2023

Completed
Last Updated

June 26, 2023

Status Verified

June 1, 2023

Enrollment Period

3 months

First QC Date

February 27, 2023

Last Update Submit

June 22, 2023

Conditions

Outcome Measures

Primary Outcomes (2)

  • To compare the CRC screening enrollment rates between the intervention and control groups.

    The proportion of people who had CRC screening who were included in the intervention group as opposed to the control group

    6 month from the start of the study

  • To assess if positive subjects are complying with follow-up screening

    The proportion of participants in the intervention group compared to the control group who tested positive and underwent a colonoscopy as a follow-up.

    6 month from the start of the study

Study Arms (2)

Certain ommunications(Nudge), community-outreach(landline call), and single FIT testing

EXPERIMENTAL

The intervention is an integrated system made up of single FIT testing, community outreach (landline call), and specific messages (Nudge). In order to encourage people to attend the screening, a primary care physician will be used in addition to text messages that participants at the outreach get for information, education, and communication (IEC).

Other: Certain ommunications(Nudge), community-outreach(landline call), and single FIT testing

Routine Care for colorectal cancer screening

NO INTERVENTION

The comparators will be individuals with an average risk of colorectal cancer of both genders attending the selected health centres / or recruited through a community outreach approach.

Interventions

The intervention is an integrated system made up of single FIT testing, community outreach (landline call), and specific messages (Nudge). In order to encourage people to attend the screening, a primary care physician will be used in addition to text messages that participants at the outreach get for information, education, and communication (IEC).

Certain ommunications(Nudge), community-outreach(landline call), and single FIT testing

Eligibility Criteria

Age40 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 40 -75

You may not qualify if:

  • Sever ill patient

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Al Hait General Hospital Zone

Hail, 12473, Saudi Arabia

RECRUITING

Related Publications (1)

  • Elfakki FAM, Alshammari KI, Aljamani MY, Alshammari WI. A nudge strategy to increase the uptake of colorectal cancer screening in Saudi Arabia: A pragmatic randomized trial in the Hail region. J Family Med Prim Care. 2024 Jan;13(1):163-168. doi: 10.4103/jfmpc.jfmpc_966_23. Epub 2024 Feb 8.

MeSH Terms

Conditions

Colorectal Neoplasms

Condition Hierarchy (Ancestors)

Intestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal DiseasesRectal Diseases

Study Officials

  • Khalil I Alshammari, VIP Chief MO

    Hail Health Cluster

    STUDY CHAIR
  • Meshari Aljamaani, MOC Lead

    New Model of Care, Hail Health Cluser

    STUDY DIRECTOR
  • Fakhralddin A Elfakki, Research Lead

    New Model of Care, Hail Health Cluster

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Fakhralddin Elfakki, Reseach Lead

CONTACT

Amir Abdullatif, PCS Lead

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: The intervention is an integrated system built on the concept of nudging and made up of a trained family doctor, community outreach (using landline calls, and a single FIT test for occult blood. Together with the information, education, and communication (IEC) texts that were sent to the outreach participants by SMS. four screening healthcare zones that included 34 public primary care facilities in the Hail region. The total sample size for the two trial arms is 2520 individuals. The calculation was done using the STATA version 15 data analysis software, the sample size command, and the cluster sizes of m1 = (60), m2 = (60), a control-group rate of (0.4), an experimental group rate of (0.6), the intraclass correlation coefficient (rho) of (0.02), a power beta of (0.8), and a sample of N1 = (1260), N2 = (1260).
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 27, 2023

First Posted

March 27, 2023

Study Start

June 15, 2023

Primary Completion

September 15, 2023

Study Completion

December 30, 2023

Last Updated

June 26, 2023

Record last verified: 2023-06

Data Sharing

IPD Sharing
Will share

The research outcome will be shared at the Saudi conference for pathway improvement

Shared Documents
CSR
Time Frame
September 2023
Access Criteria
Data will be available in August 2023

Locations